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REVIEW
Abstract: Childhood obesity has reached epidemic proportions in many countries. Pediatric
obesity is associated with the development of cardiovascular (CV) risk factors including type
2 diabetes, hypertension, dyslipidemia, and the metabolic syndrome. It is also associated
with an increased risk of CV disease (CVD) in adulthood. Moreover, obesity and CVD risk
factors in obese youth tend to track into adulthood, further increasing the risk of adult CVD.
Consequently, the treatment and prevention of childhood overweight and obesity has become
a public health priority. Proper nutrition and increased physical activity are the main focus of
these efforts; however, few studies have shown positive results. Treatment options for obesity
in youth also include pharmacotherapy and surgery. While pharmacotherapy appears promising,
additional evidence is needed, especially with respect to the long-term impact, before it becomes
a widespread treatment option in the pediatric population.
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Introduction
In the past three decades the prevalence of overweight and obesity among youth in
North America has doubled and tripled, respectively (Ogden et al 2002; Tjepkema
and Shields 2004). Childhood obesity is important from a public health perspective
for many reasons. First and foremost, obesity during childhood and adolescence is
associated with a number of cardiovascular disease (CVD) risk factors. Some of
these risk factors include type 2 diabetes mellitus (T2DM), hypertension, and
dyslipidemia. Second, obesity and many of the associated CVD risk factors have a
strong tendency to persist into adulthood. Thus, obesity during childhood and
adolescence increases adult risk of CVD. Accordingly, a considerable amount of
research resources have been devoted to this topic in recent years. This review will
discuss the prevalence of childhood and adolescent overweight and obesity, the way
in which obesity is classified, and the cardiovascular (CV) health risks associated
with it. This review will also speak to current prevention and treatment options for
obesity in youth, including the effects weight loss may have on vascular health.
Prevalence of overweight and obesity
Since the 1970s, countries around the world, developed and developing alike, have
experienced an increase in the prevalence of overweight and obesity among children
and adolescents (Chinn and Rona 2001; Strauss and Pollack 2001; Tremblay et al
2002; Lissau et al 2004). For instance, in the US the prevalence of adolescent (12 to
19 years old) obesity increased from 5% in 1976–1980 to 15% at the turn of the
century (Ogden et al 2002). Similarly, the prevalence of obesity in Canadian youth
(12 to 17 years old) has increased almost 3-fold from 3% in the late 1970’s to 8% in
2004 (Tjepkema and Shields 2004).
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A recent study (2001 to 2002) measured the prevalence
of overweight and obesity in 10 to 16 year old children from
34 countries across North America and Europe using the
international obesity classification system (Figure 1)
(Janssen et al 2005). One of the primary observations of
that study is that the childhood obesity epidemic is a global
issue: in 77% of the countries examined, at least 10% of
youth were overweight and in 20% of the countries at least
3% were obese. A second key finding of that study is that
there are regional differences in obesity. The prevalence of
overweight and obese youth is particularly high in countries
in North America, Great Britain, and southwestern European
countries such as Greece, Italy, and Spain.
Classification of overweight and
obesity
The CV health problems associated with obesity are believed
to be in large measure explained by the excess body fat in
obese individuals. While body fat can be accurately
measured using a number of techniques (eg,
hydrodensitometry, dual energy X-ray absorptiometry),
these methods are far too sophisticated, time consuming,
and expensive to employ in the clinical setting (Ellis 2000).
Instead, adiposity status is assessed in the clinical setting
using simple and practical anthropometric measures such
as the body mass index (BMI) and waist circumference.
BMI describes relative height for weight and is calculated
as weight (kg)/height squared (m
2). Studies have shown that
BMI is highly correlated to total body fat in children and
adolescents (Roche et al 1981; Deurenberg et al 1991;
Neovius et al 2005). As in adults, waist circumference is a
marker of both total and abdominal fat in children and
adolescents (Rankinen et al 1999; Rodriguez et al 2004;
Neovius et al 2005). Compared with other anthropometric
measures, waist circumference is the best overall indicator
of abdominal visceral fat levels (Rankinen et al 1999).
Abdominal visceral fat is arguably the most clinically
relevant fat depot and is associated with metabolic
complications such as hypertension, hyperinsulinemia,
T2DM, and dyslipidemia in young people (Owens et al 1998;
Freedman et al 1999; Goran and Gower 1999). However,
the quantity of visceral fat in children, even when considered
as a percentage of total fat, is quite low in comparison with
that of adults (Seidell et al 1988).
BMI values of 25 kg/m
2 and 30 kg/m
2 are used almost
universally to define overweight and obesity, respectively,
in adult populations (WHO 1997). Conversely, in children
and adolescents, the determination of adiposity status is
challenging as BMI and waist circumference change
considerably with normal growth and maturation in addition
to adiposity status (Guo et al 1997; Freedman et al 1999;
Cole et al 2000). For example, Cole and colleagues (2000)
have shown that the 50th percentile for BMI in British males
changes from approximately 16 kg/m
2 at 6 years of age to
21 kg/m
2 at 18 years of age. Similarly, waist circumference
values increase during the growing years and are higher in
males than females (Katzmarzyk 2004). Therefore, age- and
gender-specific BMI and waist circumference thresholds are
required to identify overweight and obese children and
adolescents. Thresholds for overweight and obesity are often
defined based on Caucasian populations. Caution must be
used when applying such thresholds universally, as
percentile thresholds vary with race and ethnicity (Dudeja
et al 2001). Further, evidence in children and adolescents
suggests that for a given BMI level, CVD risk factors are
different amongst different racial and ethic groups
(Srinivasan et al 1987; Klein et al 2004).
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Figure 1 Ranking of 34 countries according to the prevalence of overweight
youth in 2001–2002 using the international classification system.  Adapted from
Janssen I, Katzmarzyk PT, Boyce WF, et al. 2005. Comparison of overweight and
obesity prevalence in school-aged youth from 34 countries and their
relationships with physical activity and dietary patterns. Obes Rev, 6:123–32.
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Body mass index
BMI is the most commonly used measure of adiposity status
in children and adolescents and its use has been
recommended by several expert committees (Himes and
Dietz 1994; Barlow and Dietz 1998; Bellizzi and Dietz
1999). Two approaches can be used to classify adiposity
status in children and adolescents based on BMI. The most
common method is to use the distributional approach. With
this approach the 85th and 95th age- and gender-specific
percentiles are used to identify children as overweight and
obese, respectively (Note: some classification systems use
the terms “at-risk for overweight” and “overweight” in place
of “overweight” and “obese”). Many countries have
developed BMI-for-age growth charts for these percentiles
using representative samples of their populations (Cole et
al 1998; Leung et al 1998; Cole and Roede 1999; Must and
Strauss 1999; Fredriks et al 2000; Kuczmarski et al 2002).
In the US, the Centers for Disease Control and Prevention
(CDC) have developed BMI growth charts using data from
several representative surveys collected from 1963 to 1994
(Kuczmarski et al 2002). It should be noted that ethnic
minority groups were over-sampled in these surveys. In
addition, the BMI growth curves for children and
adolescents were primarily developed using BMI values
from older surveys (1963–1980) to account for the recent
population trends in BMI. The CDC growth charts (http://
www.cdc.gov/growthcharts/) are now widely employed in
clinical practice in the US and Canada.
The second approach commonly used to identify
overweight and obese children and adolescents is the method
of Cole and colleagues (2000). The development of these
BMI thresholds was endorsed by an expert committee
convened by the International Obesity Task Force (IOTF),
and consequently is often referred to as the IOTF method.
For the IOTF method the percentile levels corresponding
to a BMI of 25 kg/m
2 (overweight) and 30 kg/m
2 (obese) at
age 18 were identified and projected backwards into
childhood using a large (n=97 876) sample of youth from 6
countries (Britain, US, Holland, Singapore, Hong Kong,
Brazil). Thus, the IOTF thresholds are anchored to the adult
thresholds for overweight and obesity, and are a reflection
of the relationship between BMI and health risks in
adulthood rather than the relationship between BMI and
health in childhood per se.
It is important to note that the CDC BMI growth curves
are not equivalent to the BMI growth curves developed in
other countries or the IOTF curves. Figure 2 illustrates the
differences between the CDC and IOTF classification
systems. The obese IOTF threshold is higher than the CDC
threshold at most ages. This results in consistently higher
obesity prevalence based on the CDC classification system
than the IOTF classification system, with these differences
being particularly large in the younger age ranges (Flegal
et al 2001).
Two recent studies have directly compared the ability
of the CDC and IOTF classification systems to predict CVD
risk factors (Katzmarzyk et al 2004; Janssen et al 2005b).
In both studies the CDC and IOTF obesity thresholds had
similar sensitivity (correctly identifying those with high risk
values) and specificity (correctly identifying those without
high risk values) for identifying children and adolescents
with elevated CVD risk factors; however, the IOTF obesity
threshold demonstrated slightly higher specificity and
slightly lower sensitivity than the CDC obesity threshold.
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Figure 2 Comparison between the Centers for Disease Control and
Prevention (CDC) and International Obesity Task Force (IOTF) body mass index
classification systems for overweight and obesity in youth.Vascular Health and Risk Management 2006:2(2) 174
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With respect to the clinical management of adolescent
obesity, the physical exam should include an accurate
measurement of BMI that should be compared with the age
and gender appropriate BMI curves as recommended by
the CDC (http://www.cdc.gov/growthcharts/). Equally as
important as the physical exam is the assessment of patient
and family history. Secondary causes of obesity should be
identified or excluded so that the appropriate treatment can
be recommended. Secondary causes of obesity, although
rare, include endocrine (hypothyrodism and Cushing’s
disease) and genetic disorders (mutation of the
melanocortin-4-receptor and leptin deficiency) (Montague
et al 1997; Farooqi et al 2003). Most obese children and
adolescents will have “common obesity” with no endocrine
or genetic aetiology.
In patients who are obese, obesity-related health
consequences need to be identified and treated. These may
include non-CV comorbidities (orthopaedic abnormalities,
neurological and gastroentintestinal problems, asthma, and
sleep apnea) as well as CVD comorbidities (T2DM,
hypertension, and dyslipidemia) (Must and Strauss 1999).
In pediatric patients who are not obese, a complete patient
and family history will also aid in determining risk factors
for the development of obesity. Risk factors include: parental
obesity, increased birth weight, history of childhood cancer,
sedentary lifestyle, and poor eating habits. Appropriate
preventative measures should be taken before overweight
or obesity develops. These measures are discussed below.
Waist circumference
Using the percentile growth chart approach, reference
data for waist circumference in children and adolescents
have been developed in many countries such as Cuba
(Martinez et al 1994), Italy (Zannolli and Morgese 1996),
Spain (Moreno et al 1999), the UK (McCarthy et al 2001),
the US (Fernandez et al 2004), and Canada (Katzmarzyk
2004). In Canada, a recommendation has been made to
use the age- and gender-specific 90th percentile of waist
circumference to identify overweight adolescents (Figure
3). Using a percentile approach is completely arbitrary
(eg, why not use the 89th percentile instead of the 90th
percentile?), and there have been limited attempts to
develop waist circumference thresholds in children and
youth that are based on relationships with CVD risk
(Moreno et al 2002; Katzmarzyk et al 2004). Thus, a
priority for future research is the investigation of the
clinical utility of existing waist circumference percentiles,
Figure 3 Waist circumference growth curves for the 5th, 10th, 25th, 75th, 90th, and 95th percentiles for (a) males and (b) females 11–18 years of age. Data source
was the 1981 Canada Fitness Survey. Katzmarzyk PT. 2004. Waist circumference percentiles for Canadian youth 11–18 y of age. Eur J Clin Nutr, 58:1011-15. Copyright
© 2004.Vascular Health and Risk Management 2006:2(2) 175
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and the development and validation of health-based waist
circumference thresholds.
Although it has been recommended that waist
circumference be used in conjunction with BMI
measurements (Bellizzi and Dietz 1999), there has only been
a single attempt in the pediatric population to determine
how BMI and waist circumference measurements could be
used in combination to predict obesity-related health risk
(Janssen et al 2005a). When BMI (normal, overweight, or
obese) and waist circumference (low or high) values were
categorized, as would be done in a clinical setting, a high
waist circumference provided additional information
regarding CVD risk factors than that provided by BMI alone
(Janssen et al 2005a). For example, in the overweight BMI
category, children with a high waist circumference were 2.3
times more likely to have the metabolic syndrome than
children with a low waist circumference. This study provides
the first evidence to support the combined use of BMI and
waist circumference in children and adolescents. Additional
studies are warranted.
Cardiovascular health
consequences of obesity
Although the most severe complications of obesity do not
manifest until later in life, CV health consequences may
already be evident at a young age (Raitakari et al 2003).
Childhood and adolescent obesity are associated with
increased rates of hypertension, hyperlipidemia, T2DM, and
early development of atherosclerotic lesions. The presence
of these CVD risk factors does not necessarily represent
morbidity at a young age, but the increased risk of
developing CVD in adulthood. The focus of this section
will be on the association between childhood and adolescent
obesity and risk of CVD; however, it is important to mention
that obesity in young people is associated with a number of
other immediate and long-term health outcomes that fall
outside of the scope of this review.
Type 2 diabetes mellitus
Formerly considered an adult disease, T2DM has increased
alarmingly among adolescents (Fagot-Campagna et al
2000). In 1994, T2DM accounted for one third of the newly
diagnosed diabetes cases among 10 to 19 year olds (Pinhas-
Hamiel et al 1996). Ninety percent of those T2DM cases
had BMI values at or above the 90th percentile for their age
and gender.
T2DM usually develops over many years and
consequently does not display itself until adulthood.
Impaired glucose tolerance and insulin resistance are
intermediate stages in the development of T2DM (Edelstein
et al 1997). Many studies have found that impaired glucose
tolerance is presenting early in life among overweight and
obese children and adolescents (Pinhas-Hamiel et al 1996;
Sinha et al 2002; Weiss et al 2005). This suggests that the
metabolic process is accelerated in these individuals and
the transition between impaired glucose tolerance and
diabetes is shortened. For example, impaired glucose
tolerance was detected in 25% of obese children and
adolescents and T2DM was found in 4% (Sinha et al 2002).
Hyperinsulinemia, a marker of insulin resistance, is also
strongly associated with obesity during adolescence (Caprio
et al 1996). Hyperinsulinemia influences blood pressure
(through the renin–angiotensin system) and serum
lipoprotein concentrations (via increased lipolysis), and
often results in hypertension and dyslipidemia. The presence
of these conditions, in addition to obesity, has been clinically
recognized as the metabolic syndrome.
Hypertension
Blood pressure values change naturally as a function of age
and gender (Mengetti et al 1999). Table 1 illustrates the
gender, age, and height specific blood pressure values
corresponding to the 95th percentile. In children and
adolescents, systolic and/or diastolic blood pressure values
at or above the 95th percentile denote hypertension
(NHBPEP 2004). The association between hypertension and
childhood overweight and obesity has been documented in
several studies (Guillaume et al 1996; Chu et al 1998; Rosner
et al 2000; Katzmarzyk et al 2003; Genovesi et al 2005).
Rosner and colleagues (2000) conducted a meta-analysis
that included over 47 000 children to describe the
relationship between blood pressure and body size.
Compared with normal weight children, those with a BMI
≥90th percentile were 2.5 to 3.7 times more likely to have
hypertension. Furthermore, Nawrot and colleagues (2004)
report that systolic blood pressure increases by 0.8 mm Hg
per 1 kg/m
2 increase in BMI in 15 to 19 year old males and
by and 1.2 mm Hg per 1 kg/m2 increase in BMI in 15 to 19
year old females.
In general, blood pressure values have increased among
American youth over the last decade in parallel with the
rise in obesity (Muntner et al 2004). As a result, more
children and adolescents are falling into hypertensive ranges.Vascular Health and Risk Management 2006:2(2) 176
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This is of notable concern since blood pressure values tend
to track from adolescence into adulthood, especially among
those who are overweight or obese (Lauer et al 1988;
Mahoney et al 1991;  Bao et al 1995; Srinivasan et al 1996).
In the Muscatine Study, obese children had a 10 times greater
risk of developing hypertension as young adults than did
non-obese children (Lauer et al 1988). Similarly, in the
Bogalusa Heart Study youth with BMI values >75th
percentile were 8.5 times more likely to become
hypertensive as adults than were their lean counterparts
(p<0.0001) (Srinivasan et al 1996).
Dyslipidemia
Similar to blood pressure values, lipoprotein concentrations
vary with age and gender (Labarthe et al 1997; Freedman et
al 1999; Srinivasan et al 2002). An example of this effect
for total cholesterol is shown in Figure 4. Nonetheless,
current lipid and lipoprotein clinical guidelines do not reflect
these changes. Table 2 illustrates the current clinical
thresholds used by pediatricians in the US to diagnose
dyslipidemia. Obese children and adolescents have
consistently been observed to have a more unfavourable
lipid and lipoprotein profile than children and adolescents
with a normal body weight (Teixeira et al 2001; Glowinska
et al 2003; Li et al 2004; Garces et al 2005). Glowinska and
colleagues (2003), have shown that obese adolescents have
significantly higher low-density lipoprotein (LDL)
cholesterol (2.59 mmol/L vs 2.32 mmol/L, p<0.05) and
triglyceride concentrations (1.26 mmol/L vs 0.88 mmol/L,
p<0.05) and significantly lower high-density lipoprotein
(HDL) cholesterol concentrations (1.12 mmol/L vs
1.24 mmol/L, p<0.05) than age matched, lean controls.
Further, 52% of obese children 8 to 12 years old were found
to have elevated total cholesterol concentrations compared
Table 1 Hypertension cut-points (corresponding to the 95th blood pressure percentiles) for males and females according to age
and height percentiles. Adapted from tables published in National High Blood Pressure Education Program 2004
 Age, Males Females
y Systolic/Diastolic blood pressure, mm Hg Systolic/Diastolic blood pressure, mm Hg
Percentile of heighta Percentile of heighta
5th 10th 25th 50th 75th 90th 95th 5th 10th 25th 50th 75th 90th 95th
2 101/59 102/59 104/60 106/61 108/62 109/63 110/63 102/61 103/63 104/62 105/63 107/64 108/65 109/65
3 104/63 105/63 107/64 109/65 110/66 112/67 113/67 104/65 104/66 105/66 107/67 108/68 109/68 110/69
4 106/66 107/67 109/68 111/69 112/70 114/71 115/71 105/68 106/68 107/69 108/70 110/71 111/71 112/72
5 108/69 109/70 110/71 112/72 114/73 115/74 116/74 107/70 107/71 107/71 110/72 111/73 112/73 113/74
6 109/72 110/72 112/73 114/74 115/75 117/76 117/76 108/72 109/72 110/73 111/74 113/74 114/75 115/76
7 110/74 111/74 113/75 115/76 117/77 118/78 119/78 110/73 111/74 112/74 113/75 115/76 116/76 116/77
8 111/75 112/76 114/77 116/78 118/79 119/79 120/80 112/75 112/75 114/75 115/76 116/77 118/78 118/78
9 113/76 114/77 116/78 118/79 119/80 121/81 121/81 114/76 114/76 115/76 117/77 118/78 119/79 120/79
10 115/77 116/78 117/79 119/80 121/81 122/81 123/82 116/77 116/77 117/77 119/78 120/79 121/80 122/80
11 117/78 118/78 119/79 121/80 123/81 124/82 125/82 118/78 118/78 119/78 121/79 122/80 123/81 124/81
12 119/78 120/79 122/80 123/81 125/82 127/82 127/83 119/79 120/79 121/79 123/80 124/81 125/82 126/82
13 121/79 122/79 124/80 126/81 128/82 129/83 130/83 121/80 122/80 123/80 124/81 126/82 127/83 128/83
14 124/80 125/80 127/81 128/82 130/83 132/84 132/84 123/81 123/81 125/81 126/82 127/83 129/84 129/84
15 126/81 127/81 129/82 131/83 133/84 134/85 135/85 124/82 125/82 126/82 127/83 129/84 130/85 131/85
16 129/82 130/83 132/83 134/84 135/85 137/86 137/87 125/82 126/82 127/83 128/84 130/85 131/85 132/86
17 131/84 132/85 134/86 136/87 138/87 139/88 140/89 125/82 126/83 127/83 129/84 130/85 131/85 132/86
Note: a Height charts corresponding to the 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles can be found in Kuczmarski et al 2002 or http://www.cdc.gov/
growthcharts/.
Figure 4 Total cholesterol growth curves for the 50th and 75th percentiles for
male and female children 8–15 years of age. Labarthe DR, Nichaman MZ, Harrist
RB, et al. 1997. Development of cardiovascular risk factors from ages 8 to 18 in
Project Heart Beat! Study design and patterns of change in plasma total
cholesterol concentration. Circulation, 95:2636-42. Copyright © 1997.Vascular Health and Risk Management 2006:2(2) 177
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with a prevalence of 16% in non-obese children (p<0.05)
(Friedland et al 2002).
The slow development of atherosclerosis, a marker of
CVD, begins naturally at an early age; however, the rate of
progression is directly related to plasma lipoprotein
concentrations (McGill et al 1997). Given that a strong
relationship has been documented between adolescent
overweight/obesity and abnormal serum lipoprotein
concentrations (Lauer et al 1988; Caprio et al 1996), these
individuals are at increased risk of CVD later in life.
At-risk lipoprotein concentrations during the growing
years are also of particular concern because they tend to
track into adulthood (Nicklas et al 2002). As demonstrated
in the Bogalusa Heart Study, the best predictor of young
adult total cholesterol concentrations was measurements
taken 12 years prior (Webber et al 1991). Approximately
50% of children and adolescents who had total cholesterol
or LDL-cholesterol concentrations above the 75th percentile
had elevated concentrations at follow-up in young adulthood
(Webber et al 1991). In addition, overweight adolescents
who remained overweight in adulthood had a 2.4, 3, and 8
times greater prevalence of abnormal LDL-cholesterol,
triglycerides, and HDL-cholesterol concentrations,
respectively, than did those who remained lean (p<0.05 to
p<0.01) (Srinivasan et al 1996).
CVD risk factor clustering and the
metabolic syndrome
Overweight and obesity are strongly associated with
numerous CVD risk factors. Consequently, those who are
overweight tend to develop multiple risk factors. This
phenomenon is known as clustering and has been
documented among children and adolescents in several
studies (Raitakari et al 1994; Srinivasan et al 1996; Chu et
al 1998; Ribeiro et al 2004). Data from a nationally
representative sample of adolescents in the US revealed that
23% of overweight and 56% of obese youth presented with
at least 2 CVD risk factors (Cook et al 2003). In Taiwan,
the prevalence of two or more CVD risk factors was 4 to 5
times greater in overweight adolescents compared with lean
adolescents; 22% of those who were overweight had two or
more risk factors (Chu et al 1998). Similar results were
reported in Canada (Katzmarzyk et al 2003), Portugal
(Ribeiro et al 2004), and Finland (Raitakari et al 1994).
The clustering of multiple CVD risk factors is known as
the metabolic syndrome. In adults, two clinical definitions
are used to diagnose the metabolic syndrome, that of the
National Cholesterol Education Program (NCEP) Adult
Treatment Panel III (ATP-III) (NCEP 2001) and that of the
International Diabetes Federation (IDF) (Alberti et al 2005).
The NCEP defines the metabolic syndrome in adults as
having at least 3 of the following 5 criteria: elevated blood
pressure, elevated triglycerides, low HDL-cholesterol,
elevated fasting glucose levels and, a high waist
circumference. The IDF has defined the metabolic syndrome
as having a high waist circumference in addition to 2 of the
remaining 4 criteria listed above.
An established definition of the metabolic syndrome has
not yet been established for children and adolescents. A
number of studies have investigated the metabolic syndrome
in this age group and have either extrapolated from the NCEP
adult guidelines or have directly applied the adult definition
(Cook et al 2003; de Ferranti et al 2004). An example of the
adolescent guidelines used by de Ferranti and colleagues
(2004) are shown in Table 3. It is important to note that the
thresholds for each of the metabolic syndrome components
(eg, elevated blood pressure) are lower than if the disease
(eg, hypertension) were being diagnosed. For example, the
90th or 95th percentile for waist circumference is typically
used to diagnose abdominal obesity in children (Katzmarzyk
et al 2004); however, as a metabolic syndrome criterion the
75th percentile has been recommended (de Ferranti et al
2004).
Recent estimates indicate that the metabolic syndrome
is present in 29% of obese adolescents (BMI ≥95th
percentile) compared with 7% of overweight adolescents
(BMI 85th to 95th percentile) and 0.6% of adolescents with
a normal BMI (p<0.001) (Cook et al 2003). This is of
concern because the presence of multiple metabolic
disorders persists from childhood into adulthood 25%–60%
of the time (Bao et al 1994; Raitakari et al 1994) and because
Table 2 Classification of TC, LDL-C, HDL-C, and TG
concentrations in children and adolescents 2–19 years of age as
defined by the NCEP 2001
Normal Borderline–High High
TC mmol/L <4.4 4.4–5.15 ≥5.18
LDL-C mmol/L <2.85 2.85–3.34 ≥3.37
HDL-C mmol/L >1.16 0.91–1.16 <1.16
(borderline–low) (low)
TG mmol/L
 2–9  year  olds  <0.85 75–99 ≥100
10–19 year olds <1.02 1.02–1.46 ≥1.47
Abbreviations: HDL-C, high-density lipoprotein-cholesterol; LDL-C, low-
density lipoprotein-cholesterol; NCEP, National Cholesterol Education Program;
TC, total cholesterol; TG, triglycerides.Vascular Health and Risk Management 2006:2(2) 178
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the metabolic syndrome is a strong predictor of T2DM and
CVD in adulthood (Pearson et al 2002).
Adult obesity
The persistence of obesity from childhood or adolescence
into adulthood has been consistently demonstrated in the
literature and is associated with increased risk of CVD (Guo
et al 1994; Srinivasan et al 1996; Power et al 1997; Whitaker
et al 1997). Data from the Bogalusa Heart Study indicate
that 58% of adolescents who had a BMI >75th percentile
remained overweight 12 to 14 years later (Srinivasan et al
1996). Similarly, in a study conducted by Whitaker and
colleagues (1997), 64% of the study participants who were
classified as obese during early adolescence remained obese
in adulthood.
The likelihood that obesity will persist into adulthood
is related to both the severity of obesity and the age at
which it is present. Power and colleagues (1997) found
that the correlations for BMI at ages 7 and 33 years were
not very strong; however, the correlations increased with
increasing age during adolescence. Similarly, Guo and
colleagues (1994) found that BMI at age 18 was a stronger
predictor of overweight status at age 35 than was BMI at
age 13. It should also be noted that many lean adolescents
develop overweight or obesity during adulthood
(Srinivasan et al 1996; Power et al 1997). These
individuals are at increased CVD risk (Van Itallie 1985;
Raitakari et al 1994), indicating that the focus of
overweight treatment and prevention in adults should not
only be specific to those who were obese as children and
adolescents.
In adults, evidence suggests that the duration of
overweight and obesity has a detrimental effect on obesity-
related comorbidities (Muscelli et al 1998; Wannamethee
and Shaper 1999; Janssen et al 2004). For instance, Janssen
and colleagues (2004) demonstrated that by comparison with
women with a normal BMI, the likelihood of having T2DM
was increased 3-fold in women who were overweight for
less than 10 years and by 7-fold in women who were
overweight for 10 years or longer (p<0.001). It can be
inferred from these results that the development of
overweight or obesity in adolescence and its persistence into
adulthood may be associated with a higher risk of CVD
compared with adult onset obesity. The importance of
targeting obesity early on should therefore be emphasized
in efforts to decrease adult risk of CVD.
Prevention of obesity
Adolescence is a critical period of biologic, social, and
psychological development. It is also a transitional period
in which increasing independence is gained and adult
patterns and health behaviours are established. Thus, it is a
pivotal time in which to intervene and prevent the
development of overweight and obesity. Given the
continuously increasing rates of adolescent overweight and
obesity, it is clear that recent prevention strategies have been
ineffective (Summerbell et al 2005).
Gaining control of the increasing prevalence of
overweight and obesity in youth has become a public health
priority. In the US, the Institute of Medicine (IOM)
Committee on Prevention of Obesity in Children and Youth
has recently made several recommendations as part of an
Table 3 Proposed pediatric and adult definitions of the metabolic syndrome. Adapted from de Ferranti SD, Gauvreau K, Ludwig DS,
et al. 2004. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition
Examination Survey. Circulation, 110:2494-7. Copyright © 2004
Metabolic syndrome is Proposed pediatric Percentile of adult Adult
present with ≥ ≥ ≥ ≥ ≥3 of the following: definition definition definition
Hypertriglyceridemia (mmol/L) ≥1.1 75th in males 85th in females ≥1.65
Low HDL-C (mmol/L) <1.3 (15–19 yr old males, <1.17) 40th <1.04 in males
<1.3 in females
High fasting glucose (mmol/L) ≥6.1 N/A ≥6.1
Waist circumference (cm) >75th percentile for age and gender 72nd in males  >102 in males
53rd in female  >88 in females
Hypertension (mm Hg) Systolic or diastolic blood pressure N/A Systolic ≥130
>90th percentile for age and gender or diastolic ≥80Vascular Health and Risk Management 2006:2(2) 179
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action plan to decrease the prevalence of obesity in children
and adolescents (Koplan et al 2005). The ten
recommendations focus on the following aspects: federal
government, marketplace, media, local communities, and
school and home environments (Table 4). The IOM
committee also recognized that in order to achieve their
goals, changes will have to occur at many levels of society
and these changes will require coordination of federal and
state governments, local communities, and the private sector
(Koplan et al 2005).
Population-wide measures advocating energy balance,
including regular physical activity and healthy eating
behaviors, are the most common methods proposed to
prevent obesity in young people (Reilly and McDowell
2003). Since most 5–17 year olds are enrolled in school,
the school setting is ideal for health promotion education
among this age group. In a recently published Cochrane
Database systematic review, 19 of 22 childhood obesity
prevention trials were school-based (Summerbell et al 2005).
While 3 school-based trials found a reduced prevalence of
obesity in the intervention group, the remaining 16 failed
to find such a relationship.
The 3 successful school-based intervention trials tended
to be large-scale with an intervention component lasting
for at least 12 months (Summerbell et al 2005). For example,
Planet Health was a school-based randomized control trial
carried out over a 2 year period (Gortmaker et al 1999).
The study population consisted of 1295 children in 10
schools and the intervention used existing physical education
programs and teachers to target diet, physical activity, and
sedentary behaviors. The Planet Health study reported
significant declines in obesity prevalence (odds ratio
[OR]=0.47, p=0.03) and greater remission of preexisting
obesity (OR=2.16, p=0.04) among females in the
intervention group compared with those in the control group.
Conversely, New Moves was a short-term (24 weeks) trial
conducted in 201 physically inactive, overweight girls
(Neumark-Sztainer et al 2003). The intervention addressed
personal and behavioral factors and included physical
activity four times per week and nutrition and social support
sessions ever other week for 16 weeks. Despite positive
changes in behavior, no significant difference in BMI was
noted between the intervention and control groups at follow-
up (Neumark-Sztainer et al 2003).
One of the major challenges in preventing increases in
obesity is identifying a program that will induce sustained
effects after the intervention is completed. To be successful,
an intervention strategy will likely need to incorporate other
aspects of youth life outside the classroom. This could be
achieved through community-based efforts; however, there
are few studies of this nature (Fitzgibbon et al 2002;
Coleman et al 2005). The El Paso Coordinated Approach to
Child Health (CATCH) was a community-based effort
designed to use the framework of the national CATCH
program (Luepker et al 1996); however, the participating
El Paso schools were encouraged to change the program to
Table 4 Recommendations made by the Institute of Medicine Committee on Prevention of Obesity in Children and Youth
1. National priority • Governments at all levels should coordinate efforts with respect to budget, policies, and prevention
programs.
2. Industry • Leisure and entertainment industries should provide opportunities that promote physical activity.
• Food and beverage industries should develop products that consider energy density, nutrient density, and
standard portion sizes. 
3. Nutrition labelling • Labels should be clear and understandable to parents and children.
• Labels should facilitate product comparisons and wise decision making.
4. Advertising and marketing • Establish guidelines for advertising and marketing of foods, beverages, and sedentary entertainment.
5. Mutimedia and PR campaign • Develop campaigns focused on building support for policy changes, provide information to parents and
youth.
6. Community programs • Private and pubic efforts to eliminate health disparities and to address social, economic, and
environmental barriers that contribute to increased prevalence of obesity.
• Youth-centered organizations to promote healthful eating behaviours and regular physical activity. 
7. Built environment • Improve access to recreational facilities, parks, playgrounds, sidewalks, and walking and bike paths.
8. Healthcare • Pediatricians, family physicians, and nurses should engage in prevention efforts.
• Healthcare organizations and insurance companies should support individual and population-based
prevention efforts. 
9. Schools • Meal programs should meet nutritional standards.• Increased opportunity for physical activity through
physical education classes, intramural sports, and other clubs, programs, and lessons.
• Increased health curricula addressing nutrition, physical activity, and reduced sedentary behaviors.
10. Home • Provide healthful food and beverage choices; educate children in making healthy choices regarding which
foods, frequency, and portion control.
• Encourage regular physical activity; limit television viewing. Vascular Health and Risk Management 2006:2(2) 180
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fit their specific needs (Coleman et al 2005). While the
original CATCH program did not succeed in influencing
overweight outcomes, the El Paso CATCH intervention
significantly slowed the increase in risk of overweight and
obesity compared with that was seen in the control schools
(2% vs 13%). One of the reasons given for the discrepancy
between the original and the El Paso CATCH interventions
was the clinical versus community nature of the trials
respectively (eg, each school was able to tailor the CATCH
program to suit the children in their schools).
The Hip Hop to Health Jr. program is another ongoing
community-based trial (Fitzgibbon et al 2002). This program
was initiated in 2002 and is a 5-year trial that aims to alter
the trajectory towards overweight and obesity in African
American and Latino preschool children through a 14-week
dietary/physical activity curriculum (Fitzgibbon et al 2002).
The 2-year follow-up of the Hip Hop Jr. trial has shown
positive results (Fitzgibbon et al 2005). The intervention
children had significantly smaller increases in BMI at the
1-year (0.06 kg/m
2 vs 0.59 kg/m
2, p=0.01) and 2-year
(0.54 kg/m
2 vs 1.08 kg/m
2, p=0.02) follow-up periods.
Parents should also be targeted for intervention since
they contribute to adolescent’s home life. Several family-
based obesity prevention programs exist (Stolley and
Fitzgibbon 1997; Epstein et al 2001; Baranowski et al 2003),
but few have proved successful (Robinson et al 2003).
Treatment of obesity
Treatment strategies for childhood and adolescent obesity
should be multidisciplinary, supportive, and ongoing.
Parents should play an integral role in supporting the
treatment process and being active role models with respect
to eating behaviors and physical activity.
The adolescent age group can be a very difficult
population to treat for any illness or condition, including
obesity. Although treatment goals for overweight
adolescents are similar to those recommended for adults
(dietary modification and physical activity), weight loss per
se is not necessarily the best strategy (Daniels et al 2005).
In general, there is a lack of information regarding the long-
term consequence and safety of weight loss in children and
adolescents. Therefore, even a slowing of weight gain can
be beneficial, especially if the growth and maturation
process is still ongoing. For example, Weiss and colleagues
(2004) found that a slowed weight gain in obese adolescents
was associated with a delay in the development of obesity-
related metabolic disorders such as T2DM.
Dietary management and physical
activity
The American Heart Association (AHA) has recently issued
a scientific statement titled “Overweight in Children and
Adolescents” that focused on the pathophysiology,
consequences, prevention, and treatment of overweight in
youth (Daniels et al 2005). This next section is based in
large measure on the AHA statement. According to the AHA,
dietary modification combined with enhanced physical
activity is the preferred treatment strategy for obesity in
young people. The goals in dietary management are to
provide appropriate calorie intake, optimum nutrition to
facilitate normal growth, and to develop and sustain healthy
eating habits (Daniels et al 2005). Successful weight loss
and maintenance includes the incorporation of regular
physical activity into the treatment plan. The current
recommendation is for children to accumulate a minimum
of 30–60 minutes of physical activity every day.
The AHA indicated that dietary management should
emphasize balance, variety, and adequacy of overall eating
behaviors. For 4–18 year olds, the most recent Dietary
Reference Intakes recommend a fat intake of 25%–35% kcal,
a carbohydrate intake of 45%–65% kcal, and a protein intake
of 10%–30% kcal (Daniels et al 2005). Additional
recommendations include eating a variety of foods high in
fruit and vegetables and paying special attention to age-
appropriate portion sizes. Food choices should be low in
saturated fat, total fat, and cholesterol. In addition,
counseling and recommendations should be made within
the context of the family’s culture, living environment, and
socio-economic status (Daniels et al 2005).
The AHA scientific statement also recognized that
physical activity is vital to the success of weight loss and
management. It should be incorporated into a healthy
lifestyle and maintained throughout life. In order to achieve
this, the emphasis should be on active living rather than
strenuous exercise. Active living includes walking with
friends or walking the dog, dancing, bicycling, jump rope,
and skateboarding. These types of activities can be easily
integrated into daily life and should not be performed simply
to lose weight. Recommended activities should be fun and
enjoyable, as well as adaptable to their lifestyle and schedule
(Daniels et al 2005).
With respect to physical activity intervention in the
treatment of pediatric obesity, evidence is limited (Reilly
and McDowell 2003). In a systematic review conducted by
Reilly and McDowell (2003), only two high-quality studiesVascular Health and Risk Management 2006:2(2) 181
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of this nature were identified (Epstein et al 1995, 2000). In
the first study, Epstein and colleagues (1995) compared the
“traffic light” diet with one of 3 randomly allocated
treatments: 1) reduction in sedentary behavior, 2) increases
in physical activity, and 3) a combination of treatment 1
and 2. The sedentary behavior treatment group showed the
greatest change in percent overweight at the 12-month
follow-up compared with the activity treatment group (-20%
vs -12%, p<0.05). This study highlights the potential value
of targeting sedentary behavior in the treatment of childhood
obesity. These results were confirmed in the more recent
study conducted by Epstein and colleagues (2000).
In contrast to what has been recommended by the AHA,
Dorsey and colleagues (2005) found that physician-based
treatment strategies most commonly focused on dietary
changes and less often on increasing physical activity.
Advice on dietary changes was often general (eg, alter
current dietary practices) and rarely specific (eg, avoid
particular foods and control portion sizes) (Dorsey et al
2005). Rarely was there a documented plan to follow-up on
behavioral changes. Although there are several treatment
strategies that target diet and physical activity behaviors,
these approaches are not being translated into clinical
practice (Dorsey et al, 2005). Thus, efforts to treat childhood
and adolescent obesity may be better executed with the
adoption of standard diagnostic and treatment practices.
Many obesity-related CVD comorbidities can be
resolved after significant weight loss in obese youth. For
example, Reinehr and colleagues (2005) conducted a 1-year
intervention study in which children were advised by a
multidisciplinary team as to a suitable diet and necessary
physical activity and behavior patterns. They demonstrated
that a reduction in BMI standard deviation score greater
than 0.5 was associated with a significant decrease in systolic
and diastolic blood pressure (p<0.001) and triglycerides
(TG) (p<0.012), and a significant increase in HDL
cholesterol (p<0.023) (Reinehr et al 2005). More
specifically, systolic and diastolic blood pressure decreased
by a mean of 11 mm Hg and 9 mm Hg respectively, in
children who were hypertensive at baseline. In those who
were dyslipidemic at baseline LDL cholesterol decreased
by a mean of 28 mg/dL, TG decreased by a mean of 82 mg/
dL, and HDL cholesterol increased by a mean of 9 mg/dL
after the 1-year intervention program (Reinehr and Andler,
2004).
In support of these findings, Weiss and colleagues (2004)
followed 77 children over a two year period examining the
prevalence of the metabolic syndrome at baseline and again
at year 2. At baseline, 34 obese subjects met the criteria for
the metabolic syndrome; at follow-up only 24 subjects met
the criteria. The 10 subjects who no longer met the criteria
for the metabolic syndrome had gained significantly less
weight (3.74±2.6 kg vs 11.93±2.9 kg, p=0.05) over the 2-
year period.
This evidence suggests that treatment of CVD risk
factors in obese youth can be accomplished via weight
management. However, weight loss and management in
children is a contentious issue; as children and adolescents
mature their body weight and BMI will increase naturally
(Cole et al 2000). Thus, it is encouraging that increasing
physical activity even in the absence of weight loss improves
CVD risk. In adults, physical fitness is associated with
improved CVD risk factor status (Gibbons et al 1983,
Takemura et al 1999) and reduced CVD mortality (Farrell
et al 1998) independent of other potential confounding risk
factors such as adiposity. Limited evidence in children also
indicates that fitness and physical activity are related to CVD
risk factors independent of BMI and body fat (Tolfrey et al
1999). In addition, physical activity participation during
adolescence predicts physical activity levels (Telama et al
2005) and CVD risk factor profile (Twisk et al 2002) in
adulthood. Together, these findings imply that participation
in physical activity during childhood and adolescence will
positively impact CVD risk in adulthood independent of
any effects physical activity has on body weight and body
composition.
Pharmacological therapy
Two weight loss medications have been employed in
adolescent patients: sibutramine and orlistat. Both drug
therapies were originally developed for weight loss and
management in obese adults, and are intended to be used in
conjunction with behavioural therapy (including diet and
physical activity). Sibutramine acts directly on the central
nervous system by stimulating noradrenergic and
serotonergic activity, thereby causing appetite suppression
(Van Gaal et al 1998). It is currently being used in the
adolescent population for experimental purposes only and
has not yet been approved by the US Food and Drug
Administration (FDA) for use in this age group. In two
experimental trials to date, sibutramine was associated with
a significant weight reduction compared with placebo
(Berkowitz et al 2003; Godoy-Matos et al 2005). In the
original sibutramine trial, conducted by Berkowitz and
colleagues (2003), 82 obese (BMI between 32 kg/m2 andVascular Health and Risk Management 2006:2(2) 182
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44 kg/m2) male and post-menarcheal females, 12–17 years
of age, were randomized to either sibutramine plus
behavioural therapy (including diet and exercise) or to
placebo plus behavioural therapy. The sibutramine group
experienced a mean weight loss of 7.8 kg compared with a
more modest weight loss of 3.2 kg in the placebo group.
More than twice as many of those in the sibutramine group
reduced their initial BMI by 10% and 15% compared with
those receiving placebo (Berkowitz et al 2003).
Similar findings were confirmed in a second randomized
control trial conducted by Godoy-Matos and colleagues
(2005). At the end of the 6-month intervention, the
participants assigned to sibutramine lost an average of
10.3 kg while the participants in the placebo group lost
2.4 kg. Approximately 25% of adolescents in the sibutramine
group reduced their initial weight by at least 15% compared
with 0% in the placebo group.
In both sibutramine trials, no differences between the
two groups were found with respect to systolic and diastolic
blood pressures, heart rate, and biochemical parameters
(Berkowitz et al 2003; Godoy-Matos et al 2005), with the
exception of TG in one of the studies which was significantly
reduced in the sibutramine group alone (p<0.05) (Godoy-
Matos et al 2005). Both trials reported sibutramine to be
relatively well tolerated in the obese adolescent population
and no participant withdrew due to adverse effects
(Berkowitz et al 2003; Godoy-Matos et al 2005). The only
significantly different adverse event between the two groups
was constipation, which occurred in 40% of the participants
in the sibutramine group compared with 13% of those in
the placebo group (p=0.039) (Godoy-Matos et al 2005).
Orlistat is the most recent anti-obesity drug on the
market; contrary to sibutramine, it has been approved by
the FDA for use in adolescents aged 12 and older (FDA
2003). Orlistat is a lipase inhibitor, which reduces fat
absorption in the gastrointestinal tract. It acts by inhibiting
pancreatic and gastric lipase secretion thus reducing lipid
breakdown. The unabsorbed fat is excreted in feces. As a
result, the drugs’ adverse side effects include fecal
incontinence, flatulence, and oily spotting. These effects are
enhanced with consumption of fatty foods and orlistat may
therefore contribute to weight loss via the aversion of fatty
foods.
An initial non-randomized study published in 2002
examined the tolerability and effectiveness of orlistat over
3 months in a sample of 20 adolescents (McDuffie et al
2002). The adverse effects were generally mild, limited to
gastrointestinal effects, and decreased with time. Body
weight decreased by 4.4 kg (p<0.001). Orlistat use was
associated with significant improvements in total and LDL-
cholesterol, fasting insulin and glucose, and insulin
sensitivity (p<0.02).
Chanoine and colleagues (2005) conducted the first long-
term study investigating the safety and efficacy of orlistat
in the pediatric population. Obese male and female
adolescents (12 to 16 years of age) were eligible if their
BMI was at least 2 units above the respective age- and sex-
specific 95th percentile of the CDC growth curves (Chanoine
et al 2005). In total, 539 adolescents were randomized to
receive orlistat or placebo in a one year long intervention.
All participants were instructed to maintain a hypocaloric
diet designed to produce a weight loss of 0.5 kg to 1.0 kg
per week as well as encouraged to engage in regular physical
activity (Chanoine et al 2005). The orlistat group was
instructed to take 120 mg of the lipase inhibitor 3 times per
day. The placebo was administered in a similar fashion.
During the first 12 weeks of intervention, the orlistat
and placebo groups experienced a mean weight loss of
approximately 2.3 kg and 0.5 kg, respectively (Chanoine et
al 2005). Weight loss stabilized thereafter in those receiving
orlistat while those taking placebo began to gain weight.
By the end of the year-long intervention, both groups had
gained weight beyond their initial baseline weight, although
the placebo group gained significantly more (+0.53 kg vs
+3.14 kg). This effect is illustrated in Figure 5. The orlistat
group had a significantly greater decrease in waist
circumference (-1.33 cm vs +0.12 cm) as well as greater fat
loss (-2.53 kg vs +0.6 kg) compared with the placebo group
(Chanoine et al 2005). Moreover, 26% of subjects in the
orlistat group experienced a 5% or larger decrease in BMI
and 13% experienced a 10% or larger decrease in BMI
(compared with 16% and 4% of those in the placebo group).
Figure 5 The change in weight throughout a 52-week intervention of orlistat (•
symbols) and placebo (o symbols). Lifestyle modification was prescribed to both
groups. Chanoine JP, Hampl S, Jensen C, et al. 2005. Effect of orlistat on weight
and body composition in obese adolescents: a randomized controlled trial. JAMA,
293:2873-83. Copyright © 2005.Vascular Health and Risk Management 2006:2(2) 183
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This evidence suggests that a phamacotherapy approach
to the treatment of adolescent obesity is effective in the short
to medium term (1 year); however, what happens after the
first year of use is unclear. In the orlistat trial the weight of
those taking orlistat stabilized after 12 weeks and then began
to increase (Chanoine et al 2005), which leads to several
questions. Is the weight regained once drug therapy is
discontinued? Does an obese adolescent have to remain on
medication to maintain weight loss long term? If that is the
case, are there long-term side effects?
Surgery
Regardless of age, surgical management of obesity should
only be performed after intensive multidisciplinary
programs, including psychological support, have failed
(Flodmark et al 2004). Furthermore, surgery should only
be performed in centers equipped to deal with the
psychological and medical complications of the procedure.
These centers should include specialists with expertise in
adolescent obesity evaluation and management, psychology,
nutrition, and physical activity instruction (Inge et al 2004).
The two most common forms of bariatric surgery in
adolescents are Roux-en-Y gastric bypass (RYGB) and
adjustable gastric banding (AGB). In a review of bariatric
surgery for adolescents, Inge and colleagues (2004) outlined
the criteria that should be met in selecting an adolescent for
surgery (Table 5). Some of these criteria include morbid
obesity, severe obesity-related comorbidities such as T2DM
and hypertension, an understanding of the surgical
procedure, and commitment to postoperative nutritional
guidelines (Inge et al 2004; Daniels et al 2005).
There are both advantages and disadvantages of
bariatric surgery. Possibly, the greatest advantage is
weight loss and reduction of associated comorbidities
(Chapman et al 2004). The disadvantages, however, are
far more numerous. Potential complications of bariatric
surgery include intestinal leakage, incision hernia,
thromboembolitic disease, symptomatic cholelithiasis,
small bowel obstruction, and macro- and micro-nutrient
deficiencies (Sugerman et al 2003; Chapman et al 2004).
Due to the latter, micronutrients, such as calcium, folate,
thiamine, iron, vitamin B12, and multivitamins must be
supplemented long-term after surgery.
Roux-en-Y gastric bypass is the most common
bariatric surgery for the treatment of obesity among
children and adolescents. It is the safest and most
appropriate surgical option for this age group and has
been approved by the US FDA (Inge et al 2004). RYGB
divides the stomach into 2 unequal portions, leaving
approximately 5% for food consumption. RYGB is
performed laproscopically promoting less pain, faster
recovery, and quicker discharge from the hospital. In a
review of 33 adolescent patients who underwent RYGM,
Sugerman and colleagues (2003) reported successful
weight reduction in most of the patients, although 15%
of the patients regained the lost weight within 5–10 years
of surgery. Furthermore, most obesity-related
comorbidities were resolved within one year (Sugerman
et al 2003).
Adjustable gastric banding is not currently approved
by the FDA for use in children and adolescents. Thus, it
has only been performed in adolescents in experimental
settings (Stanford et al 2003; Widhalm et al 2004; Horgan
et al 2005). Briefly, AGB involves creating a small pouch
in the upper portion of the stomach with a controlled and
adjustable band. The band is adjustable; the size of the
entrance-way from the pouch to the stomach can be
altered to allow more or less food through at one time. In
a case report of 4 morbidly obese adolescents (17 to 19
years of age), AGB was successful in each case and
significant weight loss was achieved (Horgan et al 2005).
Follow-up time for each patient varied; however, at 30
months one patient had lost 57% of their initial weight
and at 12 months another patient had experienced a 34%
weight loss (Horgan et al 2005). Comparable results have
been documented in other studies (Stanford et al 2003;
Table 5 Selection criteria for adolescents to undergo bariatric
surgery as a treatment for obesity. Reproduced with
permission from Inge TH, Krebs NF, Garcia VF, et al. 2004.
Bariatric surgery for severely overweight adolescents: concerns
and recommendations. Pediatrics, 114:217-23. Copyright © 2004
Adolescents being considered for bariatric surgery should:
• Have failed >6 months of available, organized attempts at weight
management, as determined with the assistance of their primary
care givers.
• Have attained or nearly attained physiological maturity.
• Be morbidly obese (BMI ≥40 kg/mg
2) with serious obesity-related
comorbidities or have a BMI ≥50 kg/m2 with less serious
comorbidities.
• Demonstrate commitment to comprehensive medical and
psychologic evaluations both before and after surgery.
• Agree to avoid pregnancy for at least 1 year postoperatively.
• Be capable of and willing to adhere to postoperative nutritional
guidelines.
• Provide informed consent to surgical treatment.
• Demonstrate decisional capacity.
Abbreviations: BMI, body mass index.Vascular Health and Risk Management 2006:2(2) 184
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Widhalm et al 2004). Randomized control trials are
needed before AGB is considered a safe and effective
method of obesity treatment in adolescents. Regardless
of the surgical method chosen, the potential complications
such as weight regain and nutrient deficiencies lend to the
importance of a team approach.
Conclusions
Key summary recommendations on how clinicians and
other healthcare practitioners can use this information
contained in this review are contained within Table 6. As
the prevalence of overweight and obese children and
adolescents continues to rise, so will the risk of weight-
related CV complications. Although behavioral
modification, including increased physical activity and
proper nutrition, is the preferred method of treatment in
the adolescent age group, little evidence exists to suggest
this method is effective. Pharmacotherapy is gaining
popularity in adulthood and is also looking promising
for obese adolescents. It is important that drug treatment
be carried out in combination with dietary modifications
and increased physical activity to give youth the proper
tools and information needed to maintain weight loss
throughout adulthood. Furthermore, increasing physical
activity levels among adolescents will reduce many CVD
risk factors that are not necessarily affected by weight
loss (Pate et al 1996; Boreham et al 1997; Carrel et al
2005). Additional large-scale randomized control trials
assessing the long-term impact of drug treatment in the
pediatric population are required before it becomes
widely accepted.
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